看到这系列新闻，我第一反应是觉得蔡政府又在豪洨+牵拖
抱着怀疑的态度去搜寻英文泰国新闻，结果还真的让我找到这个
底下有机翻，这看起来是泰国当地的媒体
https://www.thaienquirer.com/28401/thailand-delays-astrazeneca-exports-to-othe
r-countries-as-local-inoculation-drive-begins/
https://shorturl.at/dpquA
By
Cod Satrusayang
June 10, 2021
Thailand is delaying locally-produced AstraZeneca vaccines to neighboring
countries while it focuses on inoculating its own citizens, a source told
Thai Enquirer on Thursday.
There have been problems scaling up production at Siam Bioscience, AZ’s
local partner and its sole regional producer, as has previously been reported
in Thai Enquirer. (Read more here)
Malaysia, Taiwan, and the Philippines have been informed by the Thai side
that orders for the AZ vaccine have been delayed by at least a month,
according to a report by Reuters.
The delay has been confirmed by multiple government officials across the
region. A source inside Thailand’s Ministry of Public Health told Thai
Enquirer that part of the reason for the delay is because the Thai government
has decided to focus first on inoculating its own citizens.
“I think the government has been criticized from all sides due to its
decision to heavily rely on SBS vaccines and it is especially sensitive right
now,” the source told Thai Enquirer by phone.
“So they are halting or delaying exports of the vaccine to focus on the
inoculation drive to gain back some credit.”
Thailand’s mass inoculation plans began this week on Monday and as of
Thursday morning has seen over 3 million people administered with the first
dose of the vaccine.
“I don’t know if this is going to create conflict with AstraZeneca but I do
know this is a positive decision for the Thai people,” the source added. “
The government is putting its people first even if it is to save face.”
Calls to AstraZeneca Thailand were not returned.
六月10日，2021
一位消息人士周四告诉泰国询问报，泰国正在推迟向邻国提供本地生产的阿斯利康疫苗，
同时专注于为本国公民接种疫苗。
正如泰国询问者先前报导的那样，在扩大生产规模方面，AZ 的当地合作伙伴及其唯一的
区域生产商 Siam Bioscience 出现了问题。 （在这里阅读更多）
据路透社报导，泰国方面已通知马来西亚、台湾和菲律宾，AZ疫苗的订单至少推迟了一个
月。
该地区的多位政府官员证实了这一延误。泰国公共卫生部的一位消息人士告诉《泰国询问
报》，延迟的部分原因是泰国政府决定首先专注于为本国公民接种疫苗。
“我认为政府因其决定严重依赖 SBS 疫苗而受到了各方的批评，现在特别敏感，”消息
人士通过电话告诉泰国询问者。
“因此，他们正在停止或推迟疫苗的出口，以专注于疫苗接种工作，以赢回一些信用。”
泰国的大规模接种计划于本周一开始，截至周四上午，已有超过 300 万人接种了第一剂
疫苗。
“我不知道这是否会与阿斯利康产生冲突，但我知道这对泰国人民来说是一个积极的决定
，”消息人士补充道。 “即使是为了挽回面子，政府也将人民放在首位。”
打给泰国阿斯利康的电话没有得到回复。